Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.6190
Abstract: BACKGROUND Extramammary Paget's disease (EMPD) is rare. There are no standard treatments due to its rarity and few clinical trials. METHODS The objective of this multicenter study was to investigate treatment outcomes of Korean patients… read more here.
Keywords: taxane; treatment; advanced metastatic; chemotherapy ... See more keywords
Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms
Sign Up to like & getrecommendations! Published in 2021 at "Pancreas"
DOI: 10.1097/mpa.0000000000001794
Abstract: Objectives Checkpoint inhibitors (CPIs) for low- and intermediate-grade neuroendocrine tumors (NETs) have been associated with limited efficacy; recent studies suggest CPIs may represent promising treatment for high-grade neuroendocrine neoplasms (NENs). Methods We examined 57 patients… read more here.
Keywords: patients poorly; checkpoint inhibitors; efficacy; neuroendocrine neoplasms ... See more keywords
Real-world impact of high-risk cytogenetics and revised ISS (R2 ISS) on response and survival in multiple myeloma patients treated with various induction regimens: A single-center study from India.
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-8149
Abstract: Background: Multiple myeloma (MM) is a genetically heterogeneous malignancy in which cytogenetic abnormalities play a crucial role in determining patient survival. The Revised International Staging System (R-ISS), incorporating ISS stage, LDH, and high-risk cytogenetic abnormalities,… read more here.
Keywords: pfs months; risk; high risk; risk cytogenetics ... See more keywords
Real world treatment patterns and outcomes in metastatic EGFR mutation–positive NSCLC patients: A retrospective study from a tertiary care cancer center in India.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.1582
Abstract: 1582 Background: Lung cancer is the leading cause of cancer related mortality worldwide with Non small lung cancer (NSCLC) constituting the majority of cases. EGFR mutations, predominantly exon 19 and Exon 21 L858R are actionable… read more here.
Keywords: pfs months; cancer; mutation positive; treatment ... See more keywords
Locoregional options in the management of cholangiocarcinoma: single center experience.
Sign Up to like & getrecommendations! Published in 2021 at "Annals of palliative medicine"
DOI: 10.21037/apm-19-362
Abstract: BACKGROUND The purpose of this case series is to assess the safety and efficacy, as well as the overall survival (OS) and progression free survival (PFS) of patients with intrahepatic cholangiocarcinoma (ICC) treated with percutaneous… read more here.
Keywords: pfs months; tace; remain alive; ablation ... See more keywords
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis
Sign Up to like & getrecommendations! Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16432
Abstract: Background/Aim: In the latest 2021 WHO classification of central nervous system tumours (CNS), gliomas that present isocitrate dehydrogenase (IDH) mutations are defined as diffuse low-grade gliomas (DLGGs). IDH mutations are commonly observed in this tumour… read more here.
Keywords: pfs months; 19q codeletion; codeletion; resection ... See more keywords
Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.654020
Abstract: Background Hepatocellular carcinoma (HCC) is the third most fatal cancer, with a 5-year survival rate of 18%. Standard frontline-therapy is multikinase inhibitors (MKIs), but accessibility is still limited, particularly in developing countries. This network meta-analysis… read more here.
Keywords: hepatocellular carcinoma; pfs months; median pfs; multikinase inhibitors ... See more keywords